NasdaqGM - Nasdaq Real Time Price USD

VanEck Biotech ETF (BBH)

151.75 -0.24 (-0.16%)
As of 2:22 PM EDT. Market Open.
Loading Chart for BBH
DELL
  • Previous Close 151.99
  • Open 151.88
  • Bid 151.52 x 400
  • Ask 151.74 x 600
  • Day's Range 151.75 - 152.46
  • 52 Week Range 142.51 - 171.05
  • Volume 4,248
  • Avg. Volume 7,340
  • Net Assets 452.51M
  • NAV 151.93
  • PE Ratio (TTM) 15.36
  • Yield 0.43%
  • YTD Daily Total Return -8.06%
  • Beta (5Y Monthly) 0.85
  • Expense Ratio (net) 0.35%

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

VanEck

Fund Family

Health

Fund Category

452.51M

Net Assets

2011-12-20

Inception Date

Performance Overview: BBH

Trailing returns as of 4/18/2024. Category is Health.

YTD Return

BBH
8.06%
Category
6.33%
 

1-Year Return

BBH
7.03%
Category
11.04%
 

3-Year Return

BBH
6.16%
Category
0.38%
 

People Also Watch

Holdings: BBH

Top 10 Holdings (68.04% of Total Assets)

SymbolCompany% Assets
AMGN
Amgen Inc. 14.81%
VRTX
Vertex Pharmaceuticals Incorporated 9.40%
GILD
Gilead Sciences, Inc. 8.06%
REGN
Regeneron Pharmaceuticals, Inc. 7.74%
MRNA
Moderna, Inc. 5.36%
IQV
IQVIA Holdings Inc. 4.93%
ILMN
Illumina, Inc. 4.46%
ICLR
ICON Public Limited Company 4.45%
ARGX
argenx SE 4.42%
BIIB
Biogen Inc. 4.40%

Sector Weightings

SectorBBH
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: BBH

Research Reports: BBH

  • Daily Spotlight: Demand Shifts for U.S. Debt

    Demand from all corners of the globe for the safety and security of U.S. Treasury debt has acted to keep a lid on long-term interest rates, even as the Federal Reserve has raised short-term rates aggressively over the past two-plus years and inflation has remained stubbornly high. Total public debt owed by the U.S. federal government was $34 trillion at the end of 4Q23, according to the DOT. Outside of U.S. investors, the two largest holders of U.S. public debt are Japan, which owns 3.4% of the debt, and China, which owns 2.3%. The other nations among the top 10 holders have 8% of the debt, so the top 10 holders collectively own about 14%. The grand total of U.S. debt owned by foreign holders is $8.0 trillion, or about 24% of the total. This absolute holdings level has increased 200 basis points over the past six months. Japan has been a leader here, as the nation's holdings have increased by 6%, or $55 billion in the past six months. China, meanwhile, has been selling, in part for political reasons. China's current Treasury holdings are lower by about $65 billion over the past year. Over in Europe, countries such as England, France, and Luxembourg have been buyers. We think this type of global demand for U.S. Treasuries should help keep a lid on long-term rates in 2024-2025.

     
  • Analyst Report: Elevance Health, Inc.

    Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

    Rating
    Neutral
    Price Target
     
  • VRSN: Raising target price to $201.00

    VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Neutral
    Price Target
     
  • Analyst Report: Vornado Realty Trust

    Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.

    Rating
    Neutral
    Price Target
     

Related Tickers